Carlsmed (CARL) Invested Capital (2024 - 2026)

Carlsmed has reported Invested Capital for 3 years, with the latest figure at $107.9 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 240.81% year-over-year to $107.9 million; the trailing twelve-month figure through Mar 2026 stood at $107.9 million (up 240.81% YoY), and the FY2025 full-year result was $114.2 million, up 306.85% from the prior year.
• Invested Capital for Q1 2026 stood at $107.9 million, down from $114.2 million in the prior quarter.
• The five-year high for Invested Capital was $122.1 million in Q3 2025, with the low at -$76.6 million in Q1 2025.
• Historically, Invested Capital has averaged $2.6 million across 3 years, with a median of -$56.5 million in 2024.
• The largest YoY upside for Invested Capital was 306.85% in 2025 against a maximum downside of 16.82% in 2025.
• Carlsmed's Invested Capital stood at -$55.2 million in 2024, then jumped by 306.85% to $114.2 million in 2025, then decreased by 5.55% to $107.9 million in 2026.
• The last three Invested Capital figures came in at $107.9 million (Q1 2026), $114.2 million (Q4 2025), and $122.1 million (Q3 2025), per Business Quant data.